Changing the Paradigm from Contraction of Peritoneal Dialysis Programs to Increasing Prevalent Peritoneal Dialysis Numbers
|
|
- Jemimah Wright
- 6 years ago
- Views:
Transcription
1 Advances in Peritoneal Dialysis, Vol. 29, 2013 Jennifer Cross, Andrew Davenport Changing the Paradigm from Contraction of Peritoneal Dialysis Programs to Increasing Prevalent Peritoneal Dialysis Numbers Compared with other European and North American countries, the United Kingdom traditionally had proportionally more dialysis patients treated by peritoneal dialysis. However, as in many economically developed countries, peritoneal dialysis numbers have fallen in the United Kingdom, particularly since the early 2000s. In an effort to increase home-based dialysis therapies, the U.K. Department of Health introduced a new system of reimbursement tariffs favoring peritoneal dialysis and home hemodialysis compared with standard hospital-based hemodialysis. Here, we report how our own center responded to the impending change in reimbursement rates and turned what had been a declining peritoneal dialysis program into one that almost doubled in size within 3 years. Key words Hemodialysis, reimbursement, costs, education, complications Introduction Since the early 2000s, economically developed countries have seen patient numbers continue to fall for peritoneal dialysis (PD) compared with hemodialysis (HD), whereas economically developing countries have seen the relative percentage of PD maintained, with increased total numbers (1). For example, the percentage of U.K. dialysis patients treated with PD fell to 8% in 2010 from 15% in 1995 (2). In contrast, after the introduction of universal coverage and funding of PD in Thailand, patient numbers increased 10.7% for PD compared with 12% for HD from 2007 to 2009 (3). From: UCL Centre for Nephrology, Royal Free Hospital, Pond Street, London, U.K. In economically developed countries, the paradigm of hospital-based HD has changed since the early 1990s, with the development of freestanding satellite dialysis centers. Although that trend was thought to have reduced PD numbers, studies from Canada did not show any noticeable effect on PD populations (4). Similarly, physician bias to the potential complications of PD peritonitis (5) and encapsulating peritoneal sclerosis (6,7) also does not appear to be a factor, because physician surveys have repeatedly shown that many renal clinicians support PD (8,9). Indeed, mortality of patients has been reported across many countries to be either less for those treated by PD than by HD (10), particularly during the first 18 months of treatment, or at least no different than for those treated by HD (11,12). So why are PD numbers falling in economically developed countries? Change in clinical practice as a result of increased living-donor transplantation has led to pre-emptive transplantation of younger patients who would traditionally have started on PD. Similarly, the increasing numbers of elderly patients taken onto dialysis programs with additional comorbidities and without social support preferentially start on HD (13). Thus, with a relatively high turnover of PD patients, reduction in new PD starts will reduce numbers. Even so, why are not more patients started on PD? The question is especially pertinent given that PD has been shown to be less expensive than HD for most health care systems (14), even after accounting for subsequent patient transfer costs to HD (15). In addition, physician surveys have suggested that patient choice and not physician fees or reimbursements determine the selection of dialysis modality (8,9). Indeed one Canadian study showed no change in modality choice despite a major change in physician reimbursements for PD (16).
2 Cross and Davenport 51 Discussion Why was our PD population falling? In both the United Kingdom (Figure 1) and at our own center, PD populations have fallen since the start of the 2000s. Locally, we had 153 and 156 PD patients in 2003 and 2004, but those numbers fell steadily to 72 by During that period, no increase in the number of satellite HD centers occurred, although there had been some growth in HD capacity by expanding evening dialysis shifts. However, transplantation activity increased to 115 in 2009 from 56 in 2004, predominantly because of increasing numbers of living donors. As such, the number of new starts on PD dropped to 22 in 2009 from 48 in Add in the increasing number of PD patients being transplanted because of increased kidney donations after cardiac death (to 26 in 2008 from 11 in 2005), and PD patient numbers were falling. Finance initiatives to support PD Government financial support drove the expansion of PD programs in Thailand (17), and the U.K. Department of Health introduced a pilot scheme in 2009, announcing proposed changes in health care reimbursements to National Health Service hospital dialysis providers. As part of a home-dialysis initiative, the proposed tariffs favored PD [HD 28,298 (US$44,807) and PD 26,636 (US$42,175) per patient year], which it was hoped would bring about the expansion of PD programs. Overcoming barriers to improve PD take-on rates Realizing that reimbursement tariffs for dialysis were about to change and were likely to fall over time, we carefully looked at our new starters to dialysis. Located in a large urban area and serving a migratory racially diverse population, our center started 186 patients on dialysis in Of those patients, 21% had not been seen by a renal physician before starting dialysis, 33.3% had been seen but had no established dialysis plan, and 45.7% had a planned start. Of the group that had a dialysis plan, 34% started on PD, but only 1 of the unplanned starts was sent home on PD, and once started on HD, no patient subsequently transferred to PD. Thus, to increase the number of patients starting PD, we had not only to increase the numbers in our specialist chronic kidney disease clinics opting for PD, figure 1 Change in the stock of end-stage kidney patients in England, Wales, and Northern Ireland. Data from the U.K. Renal Registry. but also to make sure that, if patients had opted for PD, a sudden and unexpected episode of acute kidney injury did not then lead to emergency HD followed by hospital discharge to HD. We also had to tackle the problem of sudden, unexpected new starters being sent home on HD. We began with an education program for the specialist chronic kidney disease clinic nurses who support our outreach clinics, because they have greatest patient contact and are involved in providing information to and educating patients about end-stage kidney disease modality choices, and because the number of referrals for PD had fallen to 42 in 2009 from 80 in It appeared that the perceptions of the nurses about the potential risks associated with PD had been overplayed and those of HD marginalized, and had of course affected the choices made by prospective dialysis patients. We therefore explained to the chronic kidney disease team that our PD infection rates were much less than those for HD with catheter access (18,19) and that the risk of other complications such as encapsulating peritoneal sclerosis were much lower than those for post-transplant proliferative disorders. To try to prevent patients who had opted for PD being started on HD because of an unexpected episode of acute kidney injury and acute hospital admission, we changed clinical practice and started to insert buried PD catheters as originally described by Moncrief and Popovich (20). In addition, we ran education programs for the in-patient nursing and medical teams
3 52 Increasing Peritoneal Dialysis Stock and actively canvassed for patients acutely admitted to hospital needing to start chronic dialysis to have PD catheters inserted so that, although the in-hospital modality was HD, patients were sent home with a PD catheter for outpatient PD training. Earlier studies have reported that elderly patients with additional comorbidities and without social support are most likely to be offered HD (13). Before 2009, the U.K. Department of Health had started an initiative to increase PD numbers by offering a limited number of elderly patients a degree of assistance for PD, in that a helper was funded to set up a PD cycler in the evening and then to dismantle the cycler the following morning. However, patients had to be able to connect to and disconnect from the cycler and to manage overnight alarms by themselves. After introduction of the proposed tariffs for PD, the money for that assistance was withdrawn. However, after successful lobbying, the Department of Health reintroduced a special tariff for assisted PD, now with the inclusion of help with connectology, thus potentially allowing nursing home residents and other frail patients to benefit from home therapies. After those innovations, the number of PD catheters inserted increased to 71 (13 embedded) in 2011 from 33 (2 embedded) in 2008, and PD numbers continue to increase (Figure 2), with more than 20 elderly patients now benefiting from assisted PD at home. Problems associated with rapid growth of a PD program As expected, a relatively rapid increase in PD patient numbers led to increased staff workload, not only in terms of training patients, but also in terms of routine work such as outpatient reviews, with testing of PD transport and dialysis adequacy (21,22). Although the increase had been anticipated and the need to recruit more trained staff appreciated, with additional nursing posts advertised to support both inpatient and outpatient PD activities, positions remained unfilled because of a lack of suitably trained candidates. Insertion of more PD catheters and increased numbers of PD patients resulted in more patients on PD being admitted to the hospital, and on one occasion, we lacked enough cyclers for all inpatients. We therefore had to increase nursing and medical staff awareness about managing PD patients and adjusting dialysis prescriptions, and also to reinforce treatment protocols and to increase education about drug dosing. figure 2 Number of patients treated with peritoneal dialysis by the UCL Centre for Nephrology at the end of each calendar year. To meet the increased workload generated from the increased number of PD catheter insertions, additional operating theatre time was required, and for the unplanned patients admitted to hospital with unrecognized uremia in particular, peritoneal catheters were often inserted on weekends and at other times outside formal operating lists. The expansion in PD numbers therefore relied heavily on the cooperation and support of our surgical colleagues. At a time when the U.K. National Health Service is looking to cut health care costs by reducing inpatient beds and length of hospital stays, we had to plan for patient discharges before PD was established. That requirement led to the development of an acute PD prescription so that PD use could start immediately after surgical catheter insertion, with a plan for reattendance for intermittent PD as an outpatient until patients could be formally trained to perform their own exchanges. Future problems After the initial pilot of shadow tariffs for dialysis reimbursement (meant to ensure that they were realistic), the real tariffs were introduced. Unfortunately, the reimbursement rates for PD and, in particular, for assisted PD are being reduced. Although the proposed tariffs for PD are lower, PD remains financially viable compared with HD (Table I). However, the reduction in payment will affect clinician choice by limiting prescription of the more expensive peritoneal dialysates. It is somewhat disappointing that, after earlier Department of Health guidelines aimed at offering assisted PD to more patients, the proposed tariff is
4 Cross and Davenport 53 table i Estimated costs a for the UCL Centre of Nephrology to deliver dialysis service (based on annual costs) and proposed reimbursement tariffs Estimated cost Tariff Net balance HD CVC 22,883 18, HD AVF 22,883 23, Home HD 18,763 23, CAPD 13,249 14, APD 16,839 18, Assisted APD 32,899 29, a In U.K. pounds (multiply by 1.55 to convert to U.S. dollars, and by 1.16 to convert to euros). The hemodialysis tariff is the same regardless of whether service is delivered in hospital, satellite, or minimal care dialysis facility. HD = hemodialysis; CVC = central venous catheter; AVF = arteriovenous fistula; CAPD = continuous ambulatory peritoneal dialysis; APD = automated peritoneal dialysis. being reduced. However, the reimbursement rates are just proposed at this point, and there may be options for change. Summary Governments and health care providers can bring influence to bear on health care provision and clinical practice by changing reimbursement rates. However, to successfully implement such changes, appropriate time is required to make the necessary changes in infrastructure and staffing. In the United Kingdom, the Department of Health proposed that all dialysis providers increase the proportion of patients treated by home dialysis therapies, be it home HD or PD. That proposal was followed by the introduction of shadow reimbursement rates in a number of pilot centers. Once those changes were deemed successful, changes in the reimbursement of dialysis modalities were introduced to favor home-based dialysis therapies. By announcing its intention and forewarning hospitals of the proposed changes, centers such as our own were able to implement changes in clinical practice and to reverse what had been a declining PD program into an expanding program, almost doubling its size within a few years. Disclosures No author has any financial conflict of interest. References 1 Jain AK, Blake P, Cordy P, Garg AX. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol 2012;23: Hemke AC, Dekker FW, Bos WJ, Krediet RT, Heemskerk MB, Hoitsma AJ. Causes of decreased use of peritoneal dialysis as a kidney replacement therapy in the Netherlands [Dutch]. Ned Tijdschr Geneeskd 2012;156:A Dhanakijcharoen P, Sirivongs D, Aruyapitipan S, Chuengsaman P, Lumpaopong A. The PD First policy in Thailand: three-years experiences ( ). J Med Assoc Thai 2011;94(suppl 4):S Prakash S, Austin PC, Oliver MJ, Garg AX, Blake PG, Hux JE. Regional effects of satellite haemodialysis units on renal replacement therapy in non-urban Ontario, Canada. Nephrol Dial Transplant 2007;22: Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit Perit Dial Int 2009;29: Balasubramaniam G, Brown EA, Davenport A, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2009;24: Habib AM, Preston E, Davenport A. Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription. Nephrol Dial Transplant 2010;25: Mendelssohn DC, Mullaney SR, Jung B, Blake PG, Mehta RL. What do American nephrologists think about dialysis modality selection? Am J Kidney Dis 2001;37: Jung B, Blake PG, Mehta RL, Mendelssohn DC. Attitudes of Canadian nephrologists toward dialysis modality selection. Perit Dial Int 1999;19: Lukowsky LR, Mehrotra R, Kheifets L, Arah OA, Nissenson AR, Kalantar Zadeh K. Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis. Clin J Am Soc Nephrol 2013;8: Chang YK, Hsu CC, Hwang SJ, et al. A comparative assessment of survival between propensity score-matched patients with peritoneal dialysis and haemodialysis in Taiwan. Medicine (Baltimore) 2012;91: Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S. Haemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 2012;27: Oliver MJ, Garg AX, Blake PG, et al. Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization. Nephrol Dial Transplant 2010;25:
5 54 Increasing Peritoneal Dialysis Stock 14 De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies an international review: costs and reimbursement/ funding of ESRD therapies. Nephrol Dial Transplant 1999;14(suppl 6): Chui BK, Manns B, Pannu N, et al. Health care costs of peritoneal dialysis technique failure and dialysis modality switching. Am J Kidney Dis 2013;61: Mendelssohn DC, Langlois N, Blake PG. Peritoneal dialysis in Ontario: a natural experiment in physician reimbursement methodology. Perit Dial Int 2004;24: Praditpornsilpa K, Lekhyananda S, Premasathian N, et al. Prevalence trend of renal replacement therapy in Thailand: impact of health economics policy. J Med Assoc Thai 2011;94(suppl 4):S Davenport A on behalf of the Pan Thames Renal Audit Peritoneal Dialysis Group. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit. J Nephrol 2012;25: Davenport A, Wellsted D on behalf of the Pan Thames Renal Audit Peritoneal Dialysis Group. Does antifungal prophylaxis with daily oral fluconazole reduce the risk of fungal peritonitis in peritoneal dialysis patients? The Pan Thames Renal Audit. Blood Purif 2011;32: Moncrief JW, Popovich RP, Seare W, et al. Peritoneal dialysis access technology: the Austin Diagnostic Clinic experience. Perit Dial Int 1996;16(suppl 1):S Davenport A, Willicombe MK. Hydration status does not influence peritoneal equilibration test ultrafiltration volumes. Clin J Am Soc Nephrol 2009;4: Papakrivopoulou E, Booth J, Pinney J, Davenport A. Comparison of volume status in asymptomatic haemodialysis and peritoneal dialysis outpatients. Nephron Extra 2012;2: U.K. National Health Service, Department of Health Payment by Results team. Draft payment by results guidance for Leeds, U.K.: Payment by Results team; [Available online at: view&gid=84&itemid=89; cited February 2013] Corresponding author: Andrew Davenport, md, UCL Centre for Nephrology, Royal Free Hospital, Pond Street, London NW3 2PF U.K. andrewdavenport@nhs.net
Acceptance onto dialysis guidelines: St George Hospital
Acceptance onto dialysis guidelines: St George Hospital The following information is a guideline to support clinicians in decision making regarding acceptance onto dialysis. A review of international guidelines
More informationTransition between home dialysis modalities another piece in the jigsaw of the integrated care pathway.
Transition between home dialysis modalities another piece in the jigsaw of the integrated care pathway. Mark Lambie and Simon J Davies Health Services Research Unit, Institute for Science and Technology
More informationAssisted Peritoneal Dialysis
Assisted Peritoneal Dialysis BC Kidney Days Vancouver, BC Matthew Oliver MD MHS Sunnybrook Health Sciences Centre University of Toronto Oct 18, 2012 Declaration 2 Co-inventor of the Dialysis Measurement
More informationChapter 3: National Renal Review 2002: summary report on adult and paediatric renal services
Chapter 3: National Renal Review : summary report on adult and paediatric renal services Summary The total annual acceptance rate of new patients for Renal Replacement Therapy (RRT) in the UK was 103.0
More informationTechnical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access
Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Louise Moist Associate Professor Lead Vascular Access Ontario Renal Network Schulich School of Medicine University
More information02/27/2018. What is a Physician Home Champion? What skills does a home champion need to have?
HOME HEMODIALYSIS SYMPOSIUM ANNUAL DIALYSIS CONFERENCE 2018 HOW CAN WE FOSTER MORE PHYSICIAN CHAMPIONS? Joel D. Glickman, M.D. Director, Home Dialysis Programs Professor of Clinical Medicine University
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES
Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationRenal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications
Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc. 2018 non-mips Measure Specifications Last updated January 2, 2018 RPAQIR1: Angiotensin Converting Enzyme (ACE)
More information21th Budapest Nephrology School Ágnes Haris, Kálmán Polner
21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 53 years old female, -worked as computer scientist, -lived with her husband and 2 children, -in excellent financial situation. Diagnosed with
More informationNew Zealand. Dialysis and Transplantation Audit
New Zealand Dialysis and Transplantation Audit Report for New Zealand Nephrology Services on behalf of the National Renal Advisory Board Grant Pidgeon Standards and Audit Subcommittee July 2012 Establishment
More informationKDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription. January 25 28, 2018 Madrid, Spain
KDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription January 25 28, 2018 Madrid, Spain Kidney Disease: Improving Global Outcomes (KDIGO) is an international organization
More informationUnited States Renal Data System (USRDS) International Data Collection Form
United States Renal Data System (USRDS) International Data Collection Form This form is designed to solicit information on the population of End-Stage Renal Disease (ESRD) patients in your country who
More informationExperts in all modalities The Expanding Role of PD Trends and Advances That Have Increased the Viability and Utilization of Peritoneal Dialysis
Experts in all modalities The Expanding Role of PD Trends and Advances That Have Increased the Viability and Utilization of Peritoneal Dialysis Todd W.B. Gehr, M.D. Professor and Chairman, Division of
More informationNephrology. 2. To facilitate a trainee to acquire the knowledge, clinical skills, procedural competence and professional attributes in Nephrology.
Nephrology I) OBJECTIVES 1. To provide a broad training and in-depth experience at a level sufficient for trainees to acquire competence and professionalism required of a specialist in Nephrology. 2. To
More informationCHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand
CHAPTER 9 End Stage Kidney Disease in Aotearoa/New Zealand ANZDATA gratefully acknowledges the patients and their families and the clinicians who provided data, and the contributions of the Aotearoa/New
More informationDialysis, personalized. More options for your patients well being.
Dialysis, personalized. More options for your patients well being. Discover the advanced peritoneal dialysis (PD) system with improved features for added control and convenience during your patients treatment
More informationSpecialised renal services and QIPP
Specialised renal services and QIPP Contents 1. Executive summary 2. Background 2.1 QIPP 2.2 Specialised renal services 3. Main themes 3.1 Need 3.2 Diagnosis 3.3 Commissioning 3.4 Treatment 3.5 Care 4.
More informationEffects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes
Original Investigation Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes Eduardo Lacson Jr, MD, MPH, Weiling Wang, MS, Cari DeVries, Keith
More informationThe Renal Physicians Association Quality Improvement Registry
In collaboration with CECity The Renal Physicians Association Quality Improvement Registry This registry is approved by CMS as a Qualified Clinical Data Registry (QCDR) for Eligible Professionals and GPRO
More informationTRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA
& TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA 2002-2008 Halima Resić* 1, Enisa Mešić 2 1 Clinic for Hemodialysis, University of Sarajevo Clinics Centre, Bolnička 25, 71000 Sarajevo, Bosnia
More informationUrgent start PD: Putting the person first
Urgent start PD: Putting the person first Arsh Jain MD, FRCPC, MSc ADC 2019 Who can we target with urgent start PD? Late or not referred Early referral Urgent dialysis start HD catheter Facility HD Who
More informationDialysis and Transplantation Audit
New Zealand Dialysis and Transplantation Audit and A summary report of activity for New Zealand nephrology services Dr Suetonia Palmer On behalf of the National Renal Advisory Board NRAB Standard and Audits
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES
Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationThe vexing problem of suboptimal initiation of dialysis: Can we do better?
Budapest Nephrology School August 30, 2010 The vexing problem of suboptimal initiation of dialysis: Can we do better? David C Mendelssohn Disclosures 2007 2010 Speaker Fees: Amgen, Ortho Biotech, Genzyme,
More informationUrgent start PD: What is it, does it work, and how can we support it?
Urgent start PD: What is it, does it work, and how can we support it? Micheli Bevilacqua, MD, FRCPC Nephrologist, FHA Clinical Assistant Professor, UBC Division of Nephrology Disclosures I have no conflicts
More informationInnovation in Technology II: Changed and Improved Design. PD Catheters- designs. Bharat Sachdeva MD LSU Shreveport
Innovation in Technology II: Changed and Improved Design PD Catheters- designs Bharat Sachdeva MD LSU Shreveport What s at risk? Why Is Material/Design Important? Reduce risk for transfer to HD Displacement
More informationKIDNEY FAILURE TREATMENT OPTIONS Choosing What s Best For You
KIDNEY FAILURE TREATMENT OPTIONS Choosing What s Best For You What Kidneys Do The kidneys are a pair of bean shaped organs located below your ribcage near the middle of your back. Kidneys play a vital
More informationTITLE: First Initiative Peritoneal Dialysis versus Hemodialysis for the Treatment of Renal Failure: A Review of Clinical Effectiveness and Guidelines
TITLE: First Initiative Peritoneal Dialysis versus Hemodialysis for the Treatment of Renal Failure: A Review of Clinical Effectiveness and Guidelines DATE: 08 February 2016 CONTEXT AND POLICY ISSUES Hemodialysis
More informationmorbidity & mortality
morbidity & mortality esrd introduction of ESRD treatment. We examine these concerns throughout the ADR, particularly in Chapter One. This year we focus on infectious complications, especially those related
More informationDESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for
DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for 2008-11 1. Aims, Outcomes and Outputs The National Service Framework Designed to Tackle Renal Disease in Wales sets standards
More informationMeeting the Guidelines for End-of-Life Care
Advances in Peritoneal Dialysis, Vol. 22, 2006 Gillian Brunier, David M.J. Naimark, Michelle A. Hladunewich Meeting the Guidelines for End-of-Life Care The number of patients initiating dialysis in most
More informationEconomic evaluation of end stage renal disease treatment Ardine de Wit G, Ramsteijn P G, de Charro F T
Economic evaluation of end stage renal disease treatment Ardine de Wit G, Ramsteijn P G, de Charro F T Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion
More informationChapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report
Chapter 12 End Stage Kidney Disease in Indigenous Peoples of and Aotearoa/ 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, the rates and practice patterns for end-stage
More informationCHAPTER 4 METHOD AND LOCATION OF DIALYSIS. Nancy Briggs Kylie Hurst Stephen McDonald Annual Report 35th Edition
CHAPTER 4 METHOD AND LOCATION OF DIALYSIS Nancy Briggs Kylie Hurst Stephen McDonald 212 Annual Report 35th Edition METHOD AND LOCATION OF DIALYSIS ANZDATA Registry 212 Report AUSTRALIA Figure 4.1 Aust
More informationStaff-Assisted Home Hemodialysis
Medical Coverage Policy Staff-Assisted Home Hemodialysis Table of Contents Coverage Policy... 1 Overview... 1 General Background... 2 Coding/Billing Information... 4 References... 4 Effective Date...11/15/2017
More informationPeritoneal Dialysis Program King Campus 2757 King Street East Hamilton, Ontario ext
Peritoneal Dialysis Program King Campus 2757 King Street East Hamilton, Ontario 905-522-1155 ext. 38275 1 Table of Contents Page What is peritoneal dialysis? 1 How does this happen? 1 What are the types
More informationPatient Education Programme. Kidney Options Guiding you when kidneys fail
Patient Education Programme Kidney Options Guiding you when kidneys fail About the kidneys What do healthy kidneys do? Your two kidneys work more than you realise. The kidneys remove excess body water
More informationCHAPTER 6 PERITONEAL DIALYSIS. Neil Boudville. Hannah Dent. Stephen McDonald. Kylie Hurst. Philip Clayton Annual Report - 36th Edition
CHAPTER 6 Neil Boudville Hannah Dent Stephen McDonald Kylie Hurst Philip Clayton 213 Annual Report - 36th Edition ANZDATA Registry 213 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis was used to treat
More information3/21/2017. Solute Clearance and Adequacy Targets in Peritoneal Dialysis. Peritoneal Membrane. Peritoneal Membrane
3/21/2017 Solute Clearance and Adequacy Targets in Peritoneal Dialysis Steven Guest MD Director, Medical Consulting Services Baxter Healthcare Corporation Deerfield, IL, USA Peritoneal Membrane Image courtesy
More informationPreservation of Veins and Timing for Vascular Access
Preservation of Veins and Timing for Vascular Access Vassilis Liakopoulos, MD, PhD Department of Nephrology School of Medicine University of Thessaly Greece Hemodialysis VA A sound long-term dialysis access
More informationCARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017
CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017 RENEGOTIATING LIFE WITH CHRONIC KIDNEY DISEASE CONSTANTINI
More informationVolume Management 2/25/2017. Disclosures statement: Objectives. To discuss evaluation of hypervolemia in peritoneal dialysis patients
Volume Management Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 14, 2017 Disclosures statement: Consultant: Allena, Becker Professional Education Grant
More informationAndrea Pizutti, LCSW Gayle Hall, BSN, RN, CNN Regional Operations Director Area Director Davita NxStage Kidney Care
Andrea Pizutti, LCSW Regional Operations Director Davita Gayle Hall, BSN, RN, CNN Area Director NxStage Kidney Care 1 Compare and contrast Home Dialysis Therapies Describe the End Stage Renal Disease patient
More informationAcceptance onto Dialysis Guidelines
Guidelines John Kelly (Kogarah, New South Wales) Melissa Stanley (Melbourne, Victoria) David Harris (Westmead, New South Wales) Date written: December 2004 Final submission: June 2005 Predialysis education
More informationPALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD
PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD Karen Solcher, MSN, APRN, NP-C, CNN-NP Nephrology Nurse Practitioner Stormont-Vail Health DISCLAIMER Adult population Clinical practice
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Blood urea sampling methods GUIDELINES
Date written: November 2004 Final submission: July 2005 Blood urea sampling methods GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions are
More informationAJNT. Original Article
. 2012 May;5(2):81-6 Original Article AJNT Reaching Target Hemoglobin Level and Having a Functioning Arteriovenous Fistula Significantly Improve One Year Survival in Twice Weekly Hemodialysis Sarra Elamin
More informationFrom Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014
From Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014 Deux grands principes concernant la DP La dialyse péritonéale doit
More informationKidney Disease Treatment Options
Page 1 Fact sheet The kidneys play a number of important roles in your body such as: extracting excess water to make urine (wee) controlling your blood pressure filtering waste products and toxins from
More informationRenal Association Clinical Practice Guideline on peritoneal dialysis in adults and children
Woodrow et al. BMC Nephrology (2017) 18:333 DOI 10.1186/s12882-017-0687-2 CORRESPONDENCE Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children Graham Woodrow 1*, Stanley
More informationChapter Five Clinical indicators & preventive health
Chapter Five Clinical indicators & preventive health The painter who draws merely by practice and by eye, without any reason, is like a mirror which copies every thing placed in front of it without being
More informationWHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington
WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have
More informationGeriatric Nutritional Risk Index, home hemodialysis outcomes 131
Subject Index Aksys PHD system 113 Anemia, home outcomes 111, 172, 173 Automated peritoneal dialysis dialysis comparison 17, 18 selection factors 18, 19 telemedicine system 19 21 Blood pressure -peritoneal
More informationIt is important upfront to realize and believe that, like many adults,
Kids With Kidney Disease Can Realize Their Dreams and Live Long, Normal, Productive Lives By Gordon Lore It is important upfront to realize and believe that, like many adults, children with kidney failure
More informationNew Zealand Nephrology Activity Report 2014
New Zealand Nephrology Activity Report Care Processes and Treatment Targets Key findings about care for people with end-stage kidney disease treated with dialysis or kidney transplantation in New Zealand
More informationNational Surveillance System for Dialysis Centre and Dialysis Associated Diseases
National Surveillance System for Dialysis Centre and Dialysis Associated Diseases Dr Richard Fluck Consultant Renal Physician & Clinical Director, Royal Derby Hospital UK RA Vascular Access Survey 2005
More informationChapter 2 Peritoneal Equilibration Testing and Application
Chapter 2 Peritoneal Equilibration Testing and Application Francisco J. Cano Case Presentation FW, a recently diagnosed patient with CKD Stage 5, is a 6-year-old boy who has been recommended to initiate
More informationCHAPTER 6 PERITONEAL DIALYSIS. Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst Annual Report 35th Edition
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst 212 Annual Report 35th Edition PERITONEAL DIALYSIS ANZDATA Registry 212 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis
More informationCanadian Organ Replacement Register Annual Report. Treatment of End-Stage Organ Failure in Canada, 2000 to 2009
Canadian Organ Replacement Register Annual Report Treatment of End-Stage Organ Failure in Canada, 2000 to 2009 January 2011 Who We Are Established in 1994, CIHI is an independent, not-for-profit corporation
More informationUpdate in Peritoneal dialysis
Update in Peritoneal dialysis Matthew Jose MBBS, FRACP, PhD, FASN, AFRACMA Royal Hobart Hospital FACULTY OF HEALTH I pay my respects to the traditional owners of this land, the Larrakia people, and to
More informationOptions in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology
Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology CKD Classification Stage Description GFR (ml/min/1.73.m2) 1 Kidney
More informationObjectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring
Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School
More informationContinuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study
Advances in Peritoneal Dialysis, Vol. 33, 2017 Kunal Malhotra, Ramesh Khanna Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study
More informationTreatment choices for someone with Stage 5 kidney disease are:
Information for patients about advanced kidney disease Dialysis and non-dialysis treatments DOCUMENT PREPARED FOR This information is to help you understand some key issues about dialysis; it is designed
More informationApril 18, Dear Mr. Blum and Dr. Conway:
April 18, 2014 Dear Mr. Blum and Dr. Conway: On behalf of the undersigned patient and health professional organizations, thank you for meeting with us Wednesday, September 18, 2013. Our organizations were
More informationA06/S(HSS)b Ex-vivo partial nephrectomy service (Adult)
A06/S(HSS)b 2013/14 NHS STANDARD CONTRACT FOR EX-VIVO PARTIAL NEPHRECTOMY SERVICE (ADULT) PARTICULARS, SCHEDULE 2 THE SERVICES, A - SERVICE SPECIFICATION Service Specification No. Service Commissioner
More informationThe Nephrology Society of Thailand has been collect THE STATUS OF, AND OBSTACLES TO, CONTINUOUS AMBULATORY PERITONEAL DIALYSIS IN THAILAND
Proceedings of the 3rd Asian Chapter Meeting of the ISPD November 22 24, 2007, Hiroshima, Japan Peritoneal Dialysis International, Vol. 28 (2008), Supplement 3 0896-8608/08 $3.00 +.00 Copyright 2008 International
More information. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less
Chapter 5: Joint Analyses with UK Transplant in England and Wales; Access to the Renal Transplant Waiting List, Time to Listing, Diabetic Access to Transplantation and the Influence of Social Deprivation
More informationUW MEDICINE PATIENT EDUCATION. Peritoneal Dialysis. A treatment option for kidney disease. There are 2 types of PD: continuous ambulatory
UW MEDICINE PATIENT EDUCATION Peritoneal Dialysis A treatment option for kidney disease Class Goals 1. Understand the purpose and basic principles of continuous ambulatory peritoneal dialysis (CAPD). 2.
More informationChapter six Outcomes: hospitalization & mortality. There is an element of death in life, and I am astonished
INTRODUCTION 1 OVERALL HOSPITALIZATION & MORTALITY 1 hospital admissions & days, by primary diagnosis & patient vintage five-year survival mortality rates, by patient vintage expected remaining lifetimes
More informationYour Kidney Health. Your Choices. Chronic Kidney Disease
Your Kidney Health Your Choices Your doctor may have told you that you have chronic kidney disease (CKD or advanced kidney disease; or, you may be in kidney failure, and may have to make a decision about
More informationKidney Decisions Aid
Kidney Decisions Aid A G U I D E F O R P E O P L E W H O H A V E, O R K N O W S O M E O N E, W I T H C H R O N I C K I D N E Y D I S E A S E, A N D T O A I D I N T H E D E C I S I O N A B O U T W H I C
More informationIntroduction To The Peritoneal Dialysis Outcomes and Practice Pattern Study
Introduction To The Peritoneal Dialysis Outcomes and Practice Pattern Study Western Canada PD Days Friday February 8, 2013 Vancouver, British Columbia Jeffrey Perl MD SM FRCP(C) Division of Nephrology
More informationThe Transitional Care Unit: An out of the box approach to expand Home Dialysis. What was US patients modality selection in 1996, 2006 and 2014?
The Transitional Care Unit: An out of the box approach to expand Home Dialysis Annual Dialysis Conference March 12, 2017 Long Beach, California Robert S. Lockridge, Jr. M.D. Retired Clinical Nephrologist
More informationUtopia Health Career Center, LLC. Do not distribute without permission.
Introduction What is dialysis and a brief history. What laws govern dialysis treatments. How to ensure high quality care for patients. How to behave in a professional way. How to become certified. We don
More informationPERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE
PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE This quick reference guide will help serve as a reference tool for clinicians setting a patient s Peritoneal Dialysis (PD) prescription.
More informationManagement of the Frail Older Patients: What Are the Outcomes
Management of the Frail Older Patients: What Are the Outcomes Professor Edwina Brown Imperial College Renal and Transplant Centre Hammersmith Hospital, London Increasing prevalence of old old on RRT RRT
More informationAdvances in Peritoneal Dialysis, Vol. 23, 2007
Advances in Peritoneal Dialysis, Vol. 23, 2007 Antonios H. Tzamaloukas, 1,2 Aideloje Onime, 1,2 Dominic S.C. Raj, 2 Glen H. Murata, 1 Dorothy J. VanderJagt, 3 Karen S. Servilla 1,2 Computation of the Dose
More informationKidney Patients with Chronic Kidney Disease
Cheshire and Merseyside Kidney Care Services Renal Replacement Therapy Options for Kidney Patients with Chronic Kidney Disease Stage 5 Renal Replacement Therapy Options for Kidney Patients with Chronic
More informationPatients with end-stage renal disease (ESRD) require extensive,
TRENDS FROM THE FIELD A Payer Provider Partnership for Integrated Care of Patients Receiving Dialysis Justin Kindy, FSA, MAAA; David Roer, MD; Robert Wanovich, PharmD; and Stephen McMurray, MD Patients
More informationASDIN 7th Annual Scientific Meeting
Strategies for Decreasing the Use of Hemodialysis Catheters ASDIN 7 th Annual Scientific Meeting Outline Late referral Primary failure Why Not PD? Summary Micah Chan MD MPH FACP Assistant Professor of
More informationCHAPTER 6 PERITONEAL DIALYSIS
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani Hannah Dent Kylie Hurst Stephen McDonald PERITONEAL DIALYSIS ANZDATA Registry 11 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis was used to
More informationImmediate Start Peritoneal Dialysis Is It Really an option? Gerry Endall PD Nurse Specialist 16 TH March 2016
4/12/2016 Page 1 Immediate Start Peritoneal Dialysis Is It Really an option? Gerry Endall PD Nurse Specialist 16 TH March 2016 4/12/2016 Page 2 Do we really need that option? Peritoneal Dialysis is a well
More informationClinical Practice Guideline Peritoneal Dialysis in Adults and Children
Clinical Practice Guideline Peritoneal Dialysis in Adults and Children Final Version: June 2017 Review Date: June 2022 Authors: Dr Graham Woodrow - Chair Consultant Nephrologist, St James s University
More informationMatching Dialysis Modality to Patient Lifestyle
A Medical Education Institute/Life Options Publication How to Use In Control Each issue of In Control offers background, tips, and patient education material on one topic that is important to living well
More informationFIRST RENAL REPLACEMENT
FIRST RENAL REPLACEMENT THERAPY SELECTION IN DIABETIC PATIENTS Dr Cécile Couchoud (REIN registry, France) Davide Bolignano (ERBP, Italy) European Renal Best Practice Prof. Wim Van Biesen Chairman of ERBP
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 10: Dialysis Providers In 2013, collectively the three large dialysis organizations treated 71% of patients in 67% of all dialysis units. In the Small Dialysis
More informationAcute Start Dialysis: Navigating for our Patients
Acute Start Dialysis: Navigating for our Patients Innovative Nursing Roles Skipper: Mina Kashani RN(EC), MN, C Neph (C), S.S. St Michael s First Mate: Diane Watson, RN(EC), C Neph (C), S.S. Toronto General
More informationDifference in practical dialysis therapy between East Asia and US/EU
Difference in practical dialysis therapy between East Asia and US/EU Jer-Ming Chang. M.D., Ph.D. 1 Professor, Attending physician, Kaohsiung Medical University Hospital; 2 Secretary General, Taiwan Society
More informationLincolnshire Knowledge and Resource Service
Lincolnshire Knowledge and Resource Service This search summary contains the results of a literature search undertaken by the Lincolnshire Knowledge and Resource Service librarians in April 2011. All of
More informationYou can sleep while I dialyze
You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep
More informationKnow The Facts About Home Dialysis Choices
Know The Facts About Home Dialysis Choices Fact Sheet www.esrdncc.org Table of Contents What are my choices for dialysis at home?...3 Why consider home hemodialysis?...4 What are the different types of
More informationCKD Prevention Program Protocol
CKD Prevention Program Protocol Taiwan Pathway as an example I. Understanding problems and situations of ESRD/CKD in Taiwan 1. Understanding the ESRD/CKD Burden 1) National Dialysis Registry since 1987
More informationSelect the dialysis treatment option that is best for you and your family.
PEP CONNECT PEP Talk Outline P a t i e n t E d u c a t i o n P r o g r a m Your Treatment Options Part 1 Peritoneal Dialysis Select the dialysis treatment option that is best for you and your family. This
More informationAPD and its new frontier. Roberto Pecoits-Filho, MD, PhD, FACP, FASN
APD and its new frontier Roberto Pecoits-Filho, MD, PhD, FACP, FASN STARCH Study Phase IV Randomised (1:1) Parallel groups Multi-centre Nephrol Dial Transpl 2015 Nov;30(11):1905-11. Non-diabetic APD
More informationConcern about the decreasing use of peritoneal dialysis
Page 1 of 8 Peritoneal Dialysis International Peritoneal Dialysis International, Vol. 30, pp. doi: 10.3747/pdi.2008.00277 0896-8608/10 $3.00 +.00 Copyright 2010 International Society for Peritoneal Dialysis
More informationThe Burden of Kidney Disease in Rural & Northern Ontario
Ontario Branch The Burden of Kidney Disease in Rural & Northern Ontario Contact: Janet Bick Director, Policy & Programs The Kidney Foundation of Canada Ontario Branch Tel: 905-278-3003/1.800-387-4474 ext.4970
More informationExamining Facility Level Data
Examining Facility Level Data for the USRDS Yi Li, PhD Professor of Biostatistics, University of Michigan, Ann Arbor Director, Kidney Epidemiology and Cost Center (KECC) Co Deputy Director, United States
More information